USE OF IBANDRONATE IN THE PREPARATION OF IBANDRONATE FILM TABLETS FOR THE TREATMENT OF CALCIUM METABOLIC DISEASES

摘要

The invention relates to pharmaceutical compositions for oral application which contain ibandronat and are well tolerated, or a physiologically tolerated salt thereof in the form of an active ingredient. The form of administration consists of an inner section containing the active ingredient and surrounded by a coating, free of the active ingredient, in such a manner that the active ingredient is released rapidly.